pre-IPO PHARMA

COMPANY OVERVIEW

Asklepion Pharmaceuticals is a Baltimore-based, biopharmaceutical company, focused on the discovery, development, and commercialization of pharmaceutical products to help patients who have little to no therapeutic options due to the rarity of their conditions.


LOCATION


THERAPEUTIC AREAS

  • Rare Diseases

  • WEBSITE

    https://www.asklepionpharm.com/


    CAREER WEBSITE

    https://www.asklepionpharm.com/about-our-company/careers/


    SOCIAL MEDIA


    INVESTORS



    PRESS RELEASES


    Nov 19, 2019

    AskBio Receives "Best Venture Funding" Award from Southeast BIO


    Nov 7, 2019

    SQZ Biotech and AskBio Announce Research Collaboration to Create Immune Tolerization Products for AAV Gene Therapies


    Oct 24, 2019

    Sheila Mikhail, AskBio CEO and Cofounder, Named Springboard Enterprises' 2019 Northstar Honoree


    Sep 17, 2019

    AskBio Acquires Assets from RoverMed BioSciences, Adds Nanotechnology Precision to Delivery of AAV Gene Therapeutics


    Aug 22, 2019

    AskBio Applauds Pfizer's Continuing Investments in Gene Therapy


    For More Press Releases


    Google Analytics Alternative